We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

125 hedge funds and large institutions have $128M invested in Alaunos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

880% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $1.6M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

41% more capital invested

Capital invested by funds: $90.5M → $128M (+$37.6M)

17% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 29

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

1% more funds holding

Funds holding: 124 → 125 (+1)

0% more ownership

Funds ownership: 0.23% → 0.23% (+0%)

Holders
125
Holders Change
+1
Holders Change %
+0.81%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
34
Reduced
29
Closed
18
Calls
$15.7M
Puts
$1.6M
Net Calls
+$14.1M
Net Calls Change
+$4.44M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$4.48M
2
BC
Boxer Capital
California
+$2.9M
3
Marshall Wace
Marshall Wace
United Kingdom
+$2.58M
4
DCM
Discovery Capital Management
Connecticut
+$1M
5
EI
EAM Investors
California
+$880K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$3.28M
2
Millennium Management
Millennium Management
New York
-$2.69M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.24M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.24M
5
E
Ergoteles
New York
-$874K
Name Holding Trade Value Shares
Change 		Change in
Stake
BF
101
BOK Financial
Oklahoma
$17K – – –
FCH
102
Freestone Capital Holdings
Washington
$17K – – –
ODG
103
O'Dell Group
Ohio
$17K – – –
CPIG
104
Chicago Partners Investment Group
Illinois
$16K – – –
BCV
105
Banque Cantonale Vaudoise
Switzerland
$14K -$290 -1 -2%
ADL
106
Asset Dedication LLC
California
$14K – – –
Rockefeller Capital Management
107
Rockefeller Capital Management
New York
$14K – – –
NFSG
108
Newbridge Financial Services Group
Florida
$10K – – –
S
109
SignatureFD
Georgia
$8K +$2.32K +8 +33%
CG
110
Cutler Group
California
$7K +$7.84K +27 New
KFI
111
Key Financial Inc
Pennsylvania
$6K – – –
Fidelity Investments
112
Fidelity Investments
Massachusetts
$4K -$3.78K -13 -43%
APA
113
American Portfolios Advisors
New York
$3.61K – – –
CUAMC
114
China Universal Asset Management Company
China
$3K +$3.78K +13 New
Parallax Volatility Advisers
115
Parallax Volatility Advisers
California
$3K +$3.78K +13 New
EPM
116
Equitec Proprietary Markets
Illinois
$2K – – –
PA
117
PSI Advisors
Florida
$2K – – –
PP
118
PFS Partners
New Jersey
$1.72K – – –
Daiwa Securities Group
119
Daiwa Securities Group
Japan
$1K – – –
HIA
120
Harbor Investment Advisory
Maryland
$1K – – –
TWA
121
TCI Wealth Advisors
Arizona
$1K – – –
Bank of Montreal
122
Bank of Montreal
Ontario, Canada
$481 +$102K +352 +29%
TAM
123
Tucker Asset Management
Colorado
$230 +$290 +1 New
Millennium Management
124
Millennium Management
New York
– -$2.69M -14,465 Closed
Point72 Asset Management
125
Point72 Asset Management
Connecticut
– -$1.24M -6,667 Closed
2 3 4
5
6

TCRT Hedge Fund Activity: Q3 2022 in Review

125 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2022, worth a combined $128M — up 41% from $90.5M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TCRT positions and 18 closed out — a net gain of 2 holders — while 34 added to existing stakes and 29 trimmed.

The largest buyer was State Street, adding an estimated $4.48M. The largest seller was JP Morgan Chase, cutting an estimated $3.28M.

  • 125 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2022, up from 124 in Q2 2022.
  • Funds reported $128M of Alaunos Therapeutics stock for Q3 2022, up 41% quarter-over-quarter.
  • 20 funds opened new Alaunos Therapeutics positions in Q3 2022 and 18 closed out, a net change of +2 holders.
  • The largest Alaunos Therapeutics buyer in Q3 2022 was State Street, an estimated $4.48M added.
  • The largest Alaunos Therapeutics seller in Q3 2022 was JP Morgan Chase, an estimated $3.28M sold.

Based on aggregated 13F filings for Q3 2022.